Cargando…

ODP009 Obesity-related Conditions in Adults with Overweight and Obesity in the United States: A Cluster Analysis

BACKGROUND: Obesity is a heterogeneous chronic condition that has varying metabolic, structural, inflammatory, degenerative, neoplastic and psychological health effects. We aimed to identify common patterns of obesity-related conditions in a nationally representative sample. METHODS: Respondents age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Kevin, Kan, Hong, MacEwan, Joanna, Shinde, Shraddha, Poon, Jiat Ling, Ahmad, Nadia Nazir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adipose Tissue, Appetite, & Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624845/ http://dx.doi.org/10.1210/jendso/bvac150.023

Ejemplares similares

Cancer Risk of Patients With Overweight and Obesity: A Predictive Model
por: Turchin, Alexander, et al.
Publicado: (2021)

SAT657 Work Loss Among Privately Insured Employees With Overweight And Obesity In The United States
por: Shinde, Shraddha, et al.
Publicado: (2023)

SUN-LB102 Development of a Conceptual Model to Present the Impacts of Obesity on Physical Functioning
por: Poon, Jiat Ling, et al.
Publicado: (2020)

ODP014 Safety and Efficacy of IBI362 (LY3305677) 9 mg and 10 mg in Chinese Adults with Overweight or Obesity
por: Ji, Linong, et al.
Publicado: (2022)

OR10-05 Improved Mental And Psychosocial Patient-Reported Outcomes Among People With Obesity Treated With Tirzepatide: Results From SURMOUNT-1 Study
por: Poon, Jiat Ling, et al.
Publicado: (2023)

ODP003 Different Phenotypes of Obesity: Focus on The Intestinal Microbiom and The Adipomyokin Profile
por: Volkova, Natalya, et al.
Publicado: (2022)

ODP607 Long-term Efficacy of Setmelanotide in Patients With POMC or LEPR Deficiency Obesity
por: Clément, Karine, et al.
Publicado: (2022)

ODP002 ASSOCIATION BETWEEN OBESITY AND DIABETES POTENTIATES RENAL FUNCTION IMPAIRMENT IN BARIATRIC PATIENTS
por: Naliato, Erika
Publicado: (2022)

ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
por: Lawrence, Rebecca, et al.
Publicado: (2022)

ODP005 Molecular Characterization of Early Adipose Tissue Remodeling and Fibrosis in a Murine Model of Diet-Induced Obesity.
por: Timms, Katie, et al.
Publicado: (2022)

SAT664 Obesity And Overweight Diagnosis, Physician Prescription And Patient Filling Of Anti-Obesity Medications In US
por: Ezendu, Kyrian, et al.
Publicado: (2023)

ODP004 Glucose Profiles and Insulin Sensitivity in Adults with Overweight/Obesity Participating in a Weight Loss Intervention based on Early Time-Restricted Eating plus Daily Caloric Restriction vs Daily Caloric Restriction Alone
por: Jeffers, Rebecca, et al.
Publicado: (2022)

ODP605 Body Mass Index and Weight Reductions in Patients With SRC1 Genetic Variant Obesity After 1 Year of Setmelanotide
por: Martos-Moreno, Gabriel Á, et al.
Publicado: (2022)

Neurobiology of Avoidant/Restrictive Food Intake Disorder in Youth With Overweight/Obesity Versus Healthy Weight
por: Liya, Kerem, et al.
Publicado: (2021)

SAT-103 Assessing Factors Influencing Eating in Overweight and Obese Individuals
por: DiBenedetti, Dana, et al.
Publicado: (2019)

SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
por: Srinath, Reshmi, et al.
Publicado: (2023)

FRI007 Kisspeptin Does Not Affect Food Intake In Women With Overweight Or Obesity
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
por: Wilding, John P H, et al.
Publicado: (2021)

SAT659 Prevalence Of Multimorbidity Across Age Groups Among Us Adults With Overweight Or Obesity
por: Ezendu, Kyrian, et al.
Publicado: (2023)

FRI009 Microbiome Affects Host Metabolic Homeostasis Via Differential Regulation Of Gene Expression In The Endocrine System
por: Milhouse, Wynne, et al.
Publicado: (2023)

SAT-096 Later Timing of Energy Intake Associates with Higher Fat Mass in Adults with Overweight and Obesity
por: Zaman, Adnin, et al.
Publicado: (2019)

FRI030 The Clinical Significance Of The Oxidative Status Evaluation Among Insulin Resistant Overweight And Obese Patients
por: Popławska-Kita, Anna, et al.
Publicado: (2023)

SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019)

Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)
por: Wilding, John P H, et al.
Publicado: (2021)

FRI050 A Cross-sectional Study Of Parental Outdoor Play Preferences And Association With Child Overweight And Obesity
por: Gavryutina, Irina, et al.
Publicado: (2023)

Efficacy and Safety of Semaglutide 2.4 MG Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)
por: Davies, Melanie, et al.
Publicado: (2021)

FRI029 Chronic Free Fatty Acid Elevation Is Associated With An Overcompensatory Increase In Hepatic Mitochondrial Function In Patients With Overweight Or Obesity
por: Bril, Fernando, et al.
Publicado: (2023)

ODP606 Long-term Efficacy of Setmelanotide in Patients With Bardet-Biedl Syndrome
por: Argente, Jesús, et al.
Publicado: (2022)

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)
por: Rubino, Domenica M, et al.
Publicado: (2021)

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study
por: Greenway, Frank, et al.
Publicado: (2019)

Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)
por: Kushner, Robert F, et al.
Publicado: (2021)

OR20-2 Oxytocin Significantly Attenuates the Functional Connectivity between Food Motivation Brain Areas in Overweight and Obese Men Exposed to High Caloric Food Images
por: Kerem, Liya, et al.
Publicado: (2019)

ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)

RF24 | PSUN110 A Cross-Sectional Study Evaluating the Impact of Combined Hormonal Contraceptives on Components of Energy Balance in Pre-Menopausal Women with Overweight or Obesity
por: Zaman, Adnin, et al.
Publicado: (2022)

ODP001 AKR1C2 Activity in Abdominal Adipose Tissue of Women with or without Excess Visceral Adiposity
por: Ostinelli, Giada, et al.
Publicado: (2022)

FRI067 Efficacy And Safety Of Glucagon-like Peptide 1 Analogs And Agonists (aGLP1) In Overweight/Obese Patients: A Systematic Review And An Updated Network Meta-analysis
por: Silva, Caroliny Hellen, et al.
Publicado: (2023)

Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021)

FRI083 Identifying Determinants Of Change In Physical Activity In Women With Obesity And Infertility Following The Obesity-Fertility Program
por: Gélinas, Myriam, et al.
Publicado: (2023)

Effects of Colchicine on Measures of Lipolysis in Adults With Obesity
por: Sarrafan-Chaharsoughi, Zahra, et al.
Publicado: (2021)

ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy
por: Nguyen, Vivien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8v7micgoa68j7l9u69asn8kvah